TrkB activation by 7, 8‐dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We recently demonstrated that activation of tyrosine receptor kinase B (TrkB) by 7, 8‐dihydroxyflavone (7, 8‐DHF), the selective TrkB agonist, increased surface alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole‐propionic acid (AMPA) receptors (AMPAR s) AMPA receptor subunit GluR1 (GluA1) subunit expression at the synapses of Fragile X Syndrome mutant mice. This present study investigated the effects of 7, 8‐DHF on both memory function and synapse structure in relation to the synapse protein level of AMPAR s in the Tg2576 Alzheimer's disease (AD) mouse model. The study found that chronic oral administration of 7, 8‐DHF significantly improved spatial memory and minimized dendrite loss in the hippocampus of Tg2576 mice. A key feature of 7, 8‐DHF action was the increased expression of both GluA1 and GluA2 at synapses. Interestingly, 7, 8‐DHF had no effect on the attenuation of amyloid precursor protein or Aβ exhibiting in the Tg2576 AD brains, yet it activated the phosphorylation of TrkB receptors and its downstream signals including Ca MKII, Akt, Erk1/2, and cAMP‐response element‐binding protein. Importantly, cyclotraxin B (a TrkB inhibitor), U0126 (a Ras‐ERK pathway inhibitor), Wortmannin (an Akt phosphorylation inhibitor), and KN‐93 (a Ca MKII inhibitor) counteracted the enhanced expression and phosphorylation of AMPAR subunits induced by 7, 8‐DHF. Collectively, our results demonstrated that 7, 8‐DHF acted on TrkB and resolved learning and memory impairments in the absence of reduced amyloid in amyloid precursor protein transgenic mice partially through improved synaptic structure and enhanced synaptic AMPAR s. The findings suggest that the application of 7, 8‐DHF may be a promising new approach to improve cognitive abilities in AD. imageWe provided extensive data demonstrating that 7, 8‐dihydroflavone, the TrkB agonist, improved Tg2576 mice spatial memory. This improvement is correlated with a reversion to normal values of GluA1 and GluA2 AMPA receptor subunits and dendritic spines in CA1. This work suggests that 7, 8‐DHF is a suitable drug to potentiate in vivo Tropomyosin receptor kinase B (TrkB) signaling in the Alzheimer's disease mice model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“For example, the 5 9 FAD model develops plaque deposition at 2 months and cognitive impairment at 4-6 months (Oakley et al. 2006).”
MethodPathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Hayashi, Y., Shi, S.-H., Esteban, J. A., Piccini, A., Poncer, J.-C., & Malinow, R. (2000) · Science · doi:10.1126/science.287.5461.2262 · Cited by 1,524 · cited 2×
“These proteins are key signal transduction modules involved in AMPAR receptor phosphorylation, delivery to the synapse (Hayashi et al. 2000; Chen et al. 2002; Poncer et al. 2002; Zhao et al. 2004; Zeng et al. 2010; Middei et al. 2013), formation of new synapses (Futter et al. 2005; Wayman et al.…”
BackgroundLacor, P. N., Buniel, M. C., Furlow, P. W., Sanz Clemente, A., Velasco, P. T., Wood, M., Viola, K. L., & Klein, W. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3501-06.2007 · Cited by 1,188 · cited 3×
“This may underlie the AD-associated learning and memory impairments (Lambert et al. 1998; Lacor et al. 2007).”
BackgroundResultKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“However, the Tg model develops plaque deposition at 9 months (Hsiao et al. 1996; Kawarabayashi et al. 2001) and cognitive impairment at 6 months (Westerman et al. 2002).”
BackgroundAMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Nagahara, A. H., Merrill, D. A., Coppola, G., Tsukada, S., Schroeder, B. E., Shaked, G. M., Wang, L., Blesch, A., Kim, A., Conner, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1912 · Cited by 1,034
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954 · cited 1×
“…of AD pathophysiology posits that increased production or reduced clearance of betaamyloid (Ab) leads to synaptic degeneration, which includes impaired synaptic plasticity and loss of synapses, and ultimately results in the neurodegenerative AD features (Lacor et al. 2004, 2007; Mattson 2004).”
BackgroundBrain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600948103 · Cited by 701
Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691
Different modes of expression of AMPA and NMDA receptors in hippocampal synapses
Takumi, Y., Ramírez-León, V., Laake, P., Rinvik, E., & Ottersen, O. P. (1999) · Nature Neuroscience · doi:10.1038/10172 · Cited by 675
Wayman, G. A., Impey, S., Marks, D., Saneyoshi, T., Grant, W. F., Derkach, V., & Soderling, T. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.008 · Cited by 466
Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses
Almeida, C. G., Tampellini, D., Takahashi, R. H., Greengard, P., Lin, M. T., Snyder, E. M., & Gouras, G. K. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.008 · Cited by 397
Amyloid beta from axons and dendrites reduces local spine number and plasticity
Wei, W., Nguyen, L. N., Kessels, H. W., Hagiwara, H., Sisodia, S., & Malinow, R. (2010) · Nature Neuroscience · doi:10.1038/nn.2476 · Cited by 357
Devi, L., & Ohno, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.191 · Cited by 282 · cited 1×
“In a few cases, 7, 8- DHF showed therapeutic efficacy in AD animal models (Devi and Ohno 2012; Bollen et al. 2013; Castello et al. 2014; Zhang et al. 2014).”
BackgroundCaldeira, M. V., Melo, C. V., Pereira, D. B., Carvalho, R., Correia, S. S., Backos, D. S., Carvalho, A. L., Esteban, J. A., & Duarte, C. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700607200 · Cited by 251
Zhang, Z., Liu, X., Schroeder, J. P., Chan, C.-B., Song, M., Yu, S. P., Weinshenker, D., & Ye, K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.243 · Cited by 242
Lanz, T. A., Carter, D. B., & Merchant, K. M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00079-2 · Cited by 227
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear
Choi, D. C., Maguschak, K. A., Ye, K., Jang, S.-W., Myers, K. M., & Ressler, K. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909359107 · Cited by 212
Liu, X., Chan, C.-B., Jang, S.-W., Pradoldej, S., Huang, J., He, K., Phun, L. H., France, S., Xiao, G., Jia, Y., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101206p · Cited by 208 · cited 2×
“Although systemic injections of a single dose of 7, 8-DHF are known to increase the phospho-TrkB level in the brain of WT rodents for 2 h (Jang et al. 2010; Liu et al. 2010; Andero et al. 2011), we found that the expression of phospho-TrkB when examined 24 h later remained stable despite the single injection.”
BackgroundPoncer, J. C., Esteban, J. A., & Malinow, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04406.2002 · Cited by 177
Itami, C., Kimura, F., Kohno, T., Matsuoka, M., Ichikawa, M., Tsumoto, T., & Nakamura, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2131948100 · Cited by 120
Nakata, H., & Nakamura, S. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.041 · Cited by 117 · cited 2×
“…(Jourdi and Kabbaj 2013) through a mechanism that involves tyrosine receptor kinase B (TrkB) (Narisawa-Saito et al. 1999, 2002; Itami et al. 2003; Du and Poo 2004; Copi et al. 2005; Caldeira et al. 2007; Nakata and Nakamura 2007; Li and Keifer 2008, 2009; Giralt et al. 2009; Keifer et al. 2009).”
Background7,8-Dihydroxyflavone improves memory consolidation processes in rats and mice
Bollen, E., Vanmierlo, T., Akkerman, S., Wouters, C., Steinbusch, H. M. W., & Prickaerts, J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.029 · Cited by 60 · cited 1×
“In a few cases, 7, 8- DHF showed therapeutic efficacy in AD animal models (Devi and Ohno 2012; Bollen et al. 2013; Castello et al. 2014; Zhang et al. 2014).”
BackgroundNo Significant Effect of 7,8-Dihydroxyflavone on APP Processing and Alzheimer-Associated Phenotypes
Zhou, W., Li, X., Huang, D., Zhou, W., Li, T., & Song, W. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666141218124243 · Cited by 19
Cited by
BDNF signaling during the lifetime of dendritic spines
Zagrebelsky, M., Tacke, C., & Korte, M. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03226-5 · Cited by 147
“In two different Alzheimer mouse models, dendritic spine loss could be prevented and spatial memory improved by the administration of 7,8-DHF and of its prodrug R13 (Chen et al. 2018; Gao et al. 2016).”
BackgroundChaudry, O., Ndukwe, K., Xie, L., Figueiredo-Pereira, M., Serrano, P., & Rockwell, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-23801-w · Cited by 28
Gao, A. Y. L., Inglebert, Y., Shi, R., Ilie, A., Popic, J., Mustian, J., Sonenberg, N., Orlowski, J., & McKinney, R. A. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167529 · Cited by 5
Metadata
- Authors
- Gao, L., Tian, M., Zhao, H., Xu, Q., Huang, Y., Si, Q., Tian, Q., Wu, Q., Hu, X., Sun, L., McClintock, S. M., & Zeng, Y.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2015-12-29
- Volume
- 136
- Issue
- 3
- Pages
- 620-636
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2181177761
- Cited by
- 77
- References
- 26
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.